Conditions: Migraine
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 71
Healthy volunteers: yes

Brief summary:
Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.

Detailed description:
Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.

Arms:

Interventions: intervention 1: eletriptan
Intervention descriptions: intervention 1: oral eletriptan 20 mg three times a day beginning 2 days before the expected onset of menstrual flow and continued for a total of 6 days

Protocol document: